The Pharmaceutical Society of Ghana (PSGH) has condemned allegations concerning some Ghanaian pharmaceutical importers’ involvement in illicit activities, calling for a stricter regulatory enforcement.
According to a statement issued on Monday February 24, 2025, most of the pharmaceutical companies have firmly denied any wrongdoing, stating that all their imports comply with Ghana’s Food and Drugs Authority (FDA) regulations and legal requirements.
“We note that some of these companies have categorically denied any wrongdoing, asserting that all their imports comply with Ghana’s FDA regulations and legal requirements”.
The Society emphasized the importance of thorough investigation, noting, “the PSGH does not absolve any entity without due investigation”.
“we emphasize the need for regulatory agencies to ensure transparency and due process in determining culpability.”
PSGH called on key regulatory bodies, including the FDA, the Pharmacy Council, and all relevant authorities to conduct an independent investigation into these allegations.
“We call on the FDA, the Pharmacy Council, GRA-Customs Division, Criminal Investigation Department of the Ghana Police Service, Narcotics Control Authority, National Intelligence Bureau, and all relevant authorities to expedite a thorough, independent investigation into these allegations”.
The Society highlighted the need for appropriate action if any local pharmaceutical company is found in breach of regulatory protocols.
“If any local pharmaceutical company is found to have breached regulatory protocols, appropriate sanctions should be enforced to maintain the integrity of the pharmaceutical supply chain in Ghana”.
It reaffirmed its commitment to ensuring that only safe and approved medicines are available in Ghana.
